173 related articles for article (PubMed ID: 28982834)
1. How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.
Polzik P; Johansson PI; Hyldegaard O
BMJ Open; 2017 Oct; 7(10):e017805. PubMed ID: 28982834
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study.
Hansen MB; Simonsen U; Garred P; Hyldegaard O
BMJ Open; 2015 May; 5(5):e006995. PubMed ID: 25967993
[TBL] [Abstract][Full Text] [Related]
3. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
5. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
[TBL] [Abstract][Full Text] [Related]
6. Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.
Haupt TH; Petersen J; Ellekilde G; Klausen HH; Thorball CW; Eugen-Olsen J; Andersen O
Crit Care; 2012 Jul; 16(4):R130. PubMed ID: 22824423
[TBL] [Abstract][Full Text] [Related]
7. suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.
Meyer J; Alstrup M; Rasmussen LJH; Schultz M; Ladelund S; Haupt TH; Tingleff J; Iversen K; Eugen-Olsen J
Scand J Trauma Resusc Emerg Med; 2018 Feb; 26(1):11. PubMed ID: 29391054
[TBL] [Abstract][Full Text] [Related]
8. [Hyperbaric oxygen therapy for necrotizing soft tissue infections: contra].
Willy C; Rieger H; Vogt D
Chirurg; 2012 Nov; 83(11):960-72. PubMed ID: 23138865
[TBL] [Abstract][Full Text] [Related]
9. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
Hansen MB
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
[TBL] [Abstract][Full Text] [Related]
11. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
[TBL] [Abstract][Full Text] [Related]
12. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections.
Shaw JJ; Psoinos C; Emhoff TA; Shah SA; Santry HP
Surg Infect (Larchmt); 2014 Jun; 15(3):328-35. PubMed ID: 24786980
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
[TBL] [Abstract][Full Text] [Related]
14. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
[TBL] [Abstract][Full Text] [Related]
15. Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry study.
Hedetoft M; Madsen MB; Hyldegaard O
BMJ Open; 2023 Feb; 13(2):e066117. PubMed ID: 36813488
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
[TBL] [Abstract][Full Text] [Related]
17. Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III).
Schultz M; Rasmussen LJH; Andersen MH; Stefansson JS; Falkentoft AC; Alstrup M; Sandø A; Holle SLK; Meyer J; Törnkvist PBS; Høi-Hansen T; Kjøller E; Jensen BN; Lind M; Ravn L; Kallemose T; Lange T; Køber L; Rasmussen LS; Eugen-Olsen J; Iversen KK
Scand J Trauma Resusc Emerg Med; 2018 Aug; 26(1):69. PubMed ID: 30153859
[TBL] [Abstract][Full Text] [Related]
18. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort study.
Hedetoft M; Madsen MB; Madsen LB; Hyldegaard O
BMJ Open; 2020 Oct; 10(10):e041302. PubMed ID: 33067303
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
[TBL] [Abstract][Full Text] [Related]
20. Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infection.
Hedetoft M; Moser C; Jensen PØ; Vinkel J; Hyldegaard O
J Appl Physiol (1985); 2021 Mar; 130(3):729-736. PubMed ID: 33444122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
